Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)

NCT00520780 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

456

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Heart Failure
Iron Deficiency
Iron Deficiency Anemia
Anaemia

Interventions

DRUG: Ferinject ® (Ferric carboxymaltose)
DRUG: Normal saline (0.9%)

Sponsor

Vifor Pharma

Collaborators

[object Object]
[object Object]